VUSION- miconazole nitrate, zinc oxide, white petrolatum ointment United States - English - NLM (National Library of Medicine)

vusion- miconazole nitrate, zinc oxide, white petrolatum ointment

mylan pharmaceuticals inc. - miconazole nitrate (unii: vw4h1cyw1k) (miconazole - unii:7nno0d7s5m), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z), petrolatum (unii: 4t6h12bn9u) (petrolatum - unii:4t6h12bn9u) - vusion ointment is indicated for the adjunctive treatment of diaper dermatitis only when complicated by documented candidiasis (microscopic evidence of pseudohyphae and/or budding yeast), in immunocompetent pediatric patients 4 weeks and older. a positive fungal culture for candida albicans is not adequate evidence of candidal infection since colonization with c. albicans can result in a positive culture. the presence of candidal infection should be established by microscopic evaluation prior to initiating treatment. vusion should be used as part of a treatment regimen that includes measures directed at the underlying diaper dermatitis, including gentle cleansing of the diaper area and frequent diaper changes. vusion should not be used as a substitute for frequent diaper changes. the safety and efficacy of vusion have not been demonstrated in immunocompromised patients, or in infants less than 4 weeks of age (premature or term). the safety and efficacy of vusion have not been evaluated in incontinent adult

TRIPLE ANTIBIOTIC HC- neomycin sulfate and polymyxin b sulfate, bacitracin zinc and hydrocortisone ointment United States - English - NLM (National Library of Medicine)

triple antibiotic hc- neomycin sulfate and polymyxin b sulfate, bacitracin zinc and hydrocortisone ointment

phoenix pharmaceutical, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - neomycin sulfate 3.5 mg in 1 g - neomycin and polymyxin b sulfates, bacitracin zinc and hydrocortisone ophthalmic ointment is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye (see clinical pharmacology: microbiology). the particular anti-infective drugs in this product

DECONGESTANT II- phenylephrine hcl tablet United States - English - NLM (National Library of Medicine)

decongestant ii- phenylephrine hcl tablet

advanced first aid, inc. - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - phenylephrine hydrochloride 5 - nasal decongestant uses:  temporarily: • relieves nasal congestion associated with sinusitis •relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies • relieves sinus congestion and pressure, helps decongest sinus openings and passages • restores freer breathing through the nose

DECONGESTANT NASAL- oxymetazoline hcl solution United States - English - NLM (National Library of Medicine)

decongestant nasal- oxymetazoline hcl solution

salado sales inc. - oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - oxymetazoline hydrochloride 0.05 g in 100 ml - purpose oxymetazoline hcl............... nasal decongestant uses  temporarily relieves nasal congestion due to:      common cold      hay fever      upper respiratory allergies  temporarily relieves sinus congestion and pressure  shrinks swollen nasal membranes so you can breathe more freely

CO RE D T- calcium carbonate tablet United States - English - NLM (National Library of Medicine)

co re d t- calcium carbonate tablet

qn science co ltd - shell powder (caco3) 45% - relieves symptoms from covid-19 or various infection. pain reliever / fever reducer / nasal decongestant covid-19 treatment supplements without side effects

CO DE R T- calcium carbonate tablet United States - English - NLM (National Library of Medicine)

co de r t- calcium carbonate tablet

qn science co ltd - shell powder (caco3) 0.45% - relieves symptoms from covid-19 or various infection. pain reliever / fever reducer / nasal decongestant covid-19 treatment supplements without side effects

Co-Careldopa 10mg/100mg Tablets Malta - English - Medicines Authority

co-careldopa 10mg/100mg tablets

brillpharma (ireland) limited inniscarra, main street, rathcoole, co. dublin, ireland - carbidopa, levodopa - tablet - carbidopa 10.8 mg levodopa 100 mg - anti-parkinson drugs

Co-Careldopa 12.5mg/50mg Tablets Malta - English - Medicines Authority

co-careldopa 12.5mg/50mg tablets

brillpharma (ireland) limited inniscarra, main street, rathcoole, co. dublin, ireland - carbidopa, levodopa - tablet - carbidopa 12.5 mg levodopa 50 mg - anti-parkinson drugs

Co-Careldopa 25mg/250mg Tablets Malta - English - Medicines Authority

co-careldopa 25mg/250mg tablets

brillpharma (ireland) limited inniscarra, main street, rathcoole, co. dublin, ireland - carbidopa, levodopa - tablet - carbidopa 25 mg levodopa 250 mg - anti-parkinson drugs

Incivo New Zealand - English - Medsafe (Medicines Safety Authority)

incivo

janssen-cilag (new zealand) ltd - telaprevir 375mg;   - film coated tablet - 375 mg - active: telaprevir 375mg   excipient: calcium hydrogen phosphate colloidal silicon dioxide croscarmellose sodium hypromellose acetate succinate iron oxide yellow macrogol 3350 microcrystalline cellulose polyvinyl alcohol purified talc sodium laurilsulfate sodium stearyl fumarate titanium dioxide - incivo, in combination with peginterferon alfa and ribavirin, is indicated for the treatment of genotype 1 chronic hepatitis c in adult patients with compensated liver disease (including cirrhosis): - who are treatment naive - who have previously been treated with interferon alfa (pegylated or nonpegylated) alone or in combination with ribavirin, including relapsers, partial responders and null responders.